Literature DB >> 34924263

Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses.

Ping Wang1, Joey Leung2, Alice Lam2, Seoyeon Lee1, Daniel R Calabrese3, Steven R Hays1, Jeffery A Golden1, Jasleen Kukreja2, Jonathan P Singer1, Paul J Wolters1, Qizhi Tang2, John R Greenland4.   

Abstract

BACKGROUND: Telomere dysfunction is associated with idiopathic pulmonary fibrosis (IPF) and worse outcomes following lung transplantation. Telomere dysfunction may impair immunity by upregulating p53 and arresting proliferation, but its influence on allograft-specific immune responses is unknown. We hypothesized that subjects undergoing lung transplantation for IPF would have impaired T cell proliferation to donor antigens.
METHODS: We analyzed peripheral blood mononuclear cells (PBMC) from 14 IPF lung transplant recipients and 12 age-matched non-IPF subjects, before and 2 years after transplantation, as well as PBMC from 9 non-transplant controls. We quantified T cell proliferation and cytokine secretion to donor antigens. Associations between PBMC telomere length, measured by quantitative PCR, and T cell proliferation to alloantigens were evaluated with generalized estimating equation models.
RESULTS: IPF subjects demonstrated impaired CD8+ T cell proliferation to donor antigens pre-transplant (p < 0.05). IL-2, IL-7, and IL-15 cytokine stimulation restored T cell proliferation, while p53 upregulation blocked proliferation. IPF subjects had shorter PBMC telomere lengths than non-IPF subjects (p < 0.001), and short PBMC telomere length was associated with impaired CD8+ T cell proliferation to alloantigens (p = 0.002).
CONCLUSIONS: IPF as an indication for lung transplant is associated with short PBMC telomere length and impaired T cell responses to donor antigens. However, the rescue of proliferation following cytokine exposure suggests that alloimmune anergy could be overcome. Telomere length may inform immunosuppression strategies for IPF recipients. Published by Elsevier Inc.

Entities:  

Keywords:  alloimmune response; idiopathic pulmonary fibrosis; immunosenescence; lung transplantation; telomeres

Mesh:

Substances:

Year:  2021        PMID: 34924263      PMCID: PMC9038662          DOI: 10.1016/j.healun.2021.11.012

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   13.569


  44 in total

1.  Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.

Authors:  Chad A Newton; David Zhang; Justin M Oldham; Julia Kozlitina; Shwu-Fan Ma; Fernando J Martinez; Ganesh Raghu; Imre Noth; Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2019-08-01       Impact factor: 21.405

2.  IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.

Authors:  Byron B Au-Yeung; Geoffrey Alexander Smith; James L Mueller; Cheryl S Heyn; Rebecca Garrett Jaszczak; Arthur Weiss; Julie Zikherman
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

3.  Short lung transplant donor telomere length is associated with decreased CLAD-free survival.

Authors:  Hilary E Faust; Jeffrey A Golden; Raja Rajalingam; Angelia S Wang; Gary Green; Steven R Hays; Jasleen Kukreja; Jonathan P Singer; Paul J Wolters; John R Greenland
Journal:  Thorax       Date:  2017-04-26       Impact factor: 9.139

4.  Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants.

Authors:  Aparna C Swaminathan; Megan L Neely; Courtney W Frankel; Fran L Kelly; Slavé Petrovski; Michael T Durheim; Erika Bush; Laurie Snyder; David B Goldstein; Jamie L Todd; Scott M Palmer
Journal:  Chest       Date:  2019-04-09       Impact factor: 9.410

Review 5.  Idiopathic Pulmonary Fibrosis.

Authors:  David J Lederer; Fernando J Martinez
Journal:  N Engl J Med       Date:  2018-05-10       Impact factor: 91.245

6.  Activation of telomerase in human lymphocytes and hematopoietic progenitor cells.

Authors:  K Hiyama; Y Hirai; S Kyoizumi; M Akiyama; E Hiyama; M A Piatyszek; J W Shay; S Ishioka; M Yamakido
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

Review 7.  Pharmacologic activation of p53 by small-molecule MDM2 antagonists.

Authors:  Hong Shen; Carl G Maki
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.

Authors:  Pornima Phatak; Fangping Dai; Melody Butler; M P Nandakumar; Peter L Gutierrez; Martin J Edelman; Hans Hendriks; Angelika M Burger
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

9.  Reversible senescence in human CD4+CD45RA+CD27- memory T cells.

Authors:  Diletta Di Mitri; Rita I Azevedo; Sian M Henson; Valentina Libri; Natalie E Riddell; Richard Macaulay; David Kipling; Maria V D Soares; Luca Battistini; Arne N Akbar
Journal:  J Immunol       Date:  2011-07-25       Impact factor: 5.422

Review 10.  The CD8 T-cell response during tolerance induction in liver transplantation.

Authors:  Yik Chun Wong; Geoffrey W McCaughan; David G Bowen; Patrick Bertolino
Journal:  Clin Transl Immunology       Date:  2016-10-14
View more
  2 in total

1.  Editorial: Immune Aging: Implications for Transplantation.

Authors:  John R Greenland; Stefan G Tullius; Joanna Schaenman
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

Review 2.  Lymphocytic Airway Inflammation in Lung Allografts.

Authors:  Jesse Santos; Daniel R Calabrese; John R Greenland
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.